Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: A randomised controlled trial

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 12, 2005, Pages 861-867

  Rossignol, M ^a,g   Allaert, F A ^b   Rozenberg, S ^c   Valat, J P ^d   Avouac, B ^e   Peres, G ^c   Le Teuff, G ^b   Bannwarth, B ^f  

^a MCGILL UNIVERSITY   (Canada)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f HÔPITAL PELLEGRIN   (France)

^g Montreal Public Health Department   (Canada)

Author keywords

Clinical guidelines; Low back pain; Pharmacoepidemiology outcome measures

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANALGESIC AGENT; ATEPADENE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; FRANCE; FUNCTIONAL ASSESSMENT; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADENOSINE TRIPHOSPHATE; ADULT; EXERCISE; FEMALE; FRANCE; HUMANS; LOW BACK PAIN; MALE; PHYSICIANS; PRACTICE GUIDELINES; PRIMARY HEALTH CARE;

EID: 30344477936     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1114     Document Type: Article

References (19)

1. Burton AK, Waddell G. Clinical guidelines in the management of low back pain. Baillieres Clin Rheumatol 1998; 12: 17-35.
2. Koes BW, van Tulder MW, Ostelo R, et al. Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine 2001; 26: 2504-2513.
3. Walsh JME, Swangard DM, Davis T, et al. Exercise counseling by primary care physicians in the era of managed care. Am J Prev Med 1999; 16: 307-313.
4. Cote P, Clarke J, Deguire S, et al. Chiropractors and return-to-work: the experiences of three groups. J Manipulative Physiol Ther 2001; 24: 309-316.
5. Jacobson KA, van Galen PJM, Williams M. Adenosine receptors: pharmacology, structure-activity relationship, and therapeutic potential. Med Chem 1992; 35: 408-422.
6. Kichenin K, Decollogne S, Angignard J, et al. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J appl Physiol 2000; 88: 1962-1968.
7. de Seze S, Bordier P. Randomised double-blind placebo-controlled trial of Atepadene® in non-specific back pain. La Gazette Medicale 1987; 90: 62-66 (in French).
8. Mathieu P, Richard M, Vignon E. Intra-muscular diffusion and efficacy of Atepadene® in non-specific back pain. Rhumatologie 1988; 40: 8 (in French).
9. Burton AK, Waddell G, Tillotson KM, et al. Information and advice to patients with back pain can have a positive effect. Spine 1999; 24: 2484-2491.
10. Coste J, Le Parc JM, Berge E, et al. French validation of a disability rating scale for the evaluation of low back pain (EIFEL questionnaire). Rev Rhum 1993; 60: 335-341 (in French).
11. Rozenberg S, Delval C, Rezvani Y, et al. Bed rest or normal activity for patients with acute low back pain: a randomized controlled trial. Spine 2002; 27: 1487-1493.
12. Bannwarth B, Allaert FA, Avouac B, et al. Efficacy of oral Adenosine Triphosphate on the functional recovery of subacute low-back pain patients. Rev Rhum 2003; 70: 874 (in French).
13. Beaton DE. Understanding the relevance of measured change through studies of responsiveness. Spine 2000; 25: 3192-3199.
14. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of the Roland-Morris back pain questionnaire: part I. Phys Ther 1998; 78: 1186-1196.
15. van Tulder MW, Scholten RJ, Koes BW, et al. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000; 25: 2501-2513.
16. van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003; 2: CD004252.
17. van Tulder MW, Croft PR, van Splunteren P, et al. Disseminating and implementing the results of back pain research in primary care. Spine 2002; 27: E121-E127.
18. Hagen KB, Hilde G, Jamtvedt G, Winnem MF. The cochrane review of advice to stay active as a single treatment for low back pain and sciatica. Spine 2002; 27: 1736-1741.
19. Abenhaim L, Rossignol M, Valat JP, et al. The role of activity in the therapeutic management of back pain. Report of the International Paris Task Force on Back Pain. Spine 2000; 25: 1S-33S.